This study is currently not recruiting participants.
THE PRIORITIZE STUDY: A Pragmatic Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients Providers and Stakeholders
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study.
The purpose of this study is to compare the effectiveness of three different FDA-approved medicines for Hepatitis C Genotype 1 patients.
Detailed description of study
The purpose of this study is to compare the effectiveness of three different FDA-approved medicines for Hepatitis C Genotype 1 patients.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:hepatitis C
Age:
100 years or below
Gender: All
Updated on
29 Sep 2016.
Study ID: 1604551710
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
